Iveda Solutions, Inc.

Our common stock is listed on The Nasdaq Capital Market under the symbol “IVDA” since April 1, 2022. Set forth in the table below is information with respect to the high and low bid quotations of our common stock for the periods indicated as reported by NASDAQ and the OTC Markets. The quotations represent inter-dealer prices without retail mark-ups, mark-downs, or commissions and may not necessarily represent actual transactions.

See the High and Low Bid data below:

There is limited trading activity in our securities, and there can be no assurance that a regular trading market for our common stock will be sustained.

Security Holders

As of December 31, 2025, we had 5,879,741 shares of our common stock, par value $0.00001, issued and outstanding held by 96 shareholders of record and approximately 25,000 beneficial owners, 0 shares of our Series A Preferred Stock outstanding and 0 shares of our series B Preferred Stock.

Dividend Policy

We have never paid a cash dividend on our common stock. We currently intend to retain all earnings, if any, to finance the growth and development of our business. We do not anticipate paying any cash dividends in the foreseeable future.

Equity Compensation Plans

For equity compensation plans information refer to Item 12 of Part III of this Annual Report on Form 10-K.

Recent Sales of Unregistered Securities

Set forth below are the sales of all securities by the Company within the past three years which were not registered under the Securities Act. The Company believes that each of such issuances was exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act and/or Regulation S under the Securities Act.

Between January 1, 2023 and December 31, 2023 the Company issued 19,656 shares of restricted common stock for services valued at $138,547.

Between January 1, 2024 and December 31, 2024 the Company issued 12,500 shares of restricted common stock for services valued at $90,000.

Between January 1, 2025 and December 31, 2025 the Company issued 100,000 shares of restricted common stock for services valued at $135,000.

All of the securities referred to, above, were issued without registration under the Securities Act of 1933, as amended (the “Securities Act”) in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as provided in Rule 506(b) of Regulation D promulgated thereunder.

On February 11, 2026, the Company consummated a public offering of (i) 5,259,999 shares of the Company’s common stock, par value $0.00001 per share at an offering price of $0.35 per share of common stock, and (ii) pre-funded warrants to purchase up to 454,287 shares of common stock, at an offering price of $0.3499 per pre-funded warrant and (iii) accompanying series x warrants to purchase up to 11,428,572 shares of common stock and accompanying Series X Warrants. H.C. Wainwright & Co., LLC acted as the placement agent in connection with the offering and received a cash fee of 7% in the amount of $140,000 and was issued placement agent warrants to purchase up to 400,000 shares of common stock. The shares of common stock, pre-funded warrants, series x warrants, placement agent warrants, and the shares of common stock underlying the pre-funded warrants, series x warrants, and placement agent warrants issued in the offering were offered pursuant to the Company’s registration statement on Form S-1, as amended (File No. 333-293126) initially filed with the SEC under the Securities Act, on February 2, 2026, and declared effective by the SEC on February 9, 2026.